mRESVIA 50 ug/.5mL
Respiratory Syncytial Virus Vaccine · SUSPENSION · Moderna US, INC.
No Recall History
Plain English
mRESVIA is a suspension containing respiratory syncytial virus vaccine at 50 ug/.5mL, taken intramuscular. Manufactured by Moderna US, INC..
Key Facts
- Brand Name
- mRESVIA
- Generic Name
- Respiratory Syncytial Virus Vaccine
- NDC Code (Product)
80777-345- Manufacturer
- Moderna US, INC.
- Strength
- 50 ug/.5mL
- Dosage Form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125796
- Marketing Start
- 05/31/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is mRESVIA used for?
mRESVIA contains Respiratory Syncytial Virus Vaccine. It is a suspension taken intramuscular. Consult your doctor for specific uses.
Is mRESVIA a controlled substance?
mRESVIA is not classified as a controlled substance by the DEA.
What is the generic name for mRESVIA?
The generic name for mRESVIA is Respiratory Syncytial Virus Vaccine. There are 5 other brand versions of Respiratory Syncytial Virus Vaccine.
What is the NDC code for mRESVIA 50 ug/.5mL?
The NDC (National Drug Code) for mRESVIA 50 ug/.5mL is 80777-345, listed by Moderna US, INC..